Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LUBIPROSTONE vs LUCENTIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LUBIPROSTONE vs LUCENTIS: Safety Overview

Metric LUBIPROSTONE LUCENTIS
Total FAERS Reports 1,214 686
Deaths Reported 118 184
Death Rate 9.7% 26.8%
Hospitalizations 332 180
Average Patient Age 64.0 yrs 71.6 yrs
% Female Patients 66.5% N/A
FDA Approval Date Apr 29, 2008 N/A
Manufacturer Direct_Rx N/A
Route ORAL N/A
Marketing Status Prescription N/A